Prehospital use of intravenous verapamil
Verapamil was introduced into a hospital-based urban/rural advanced life support (ALS) system for intravenous (IV) use in patients with symptomatic supraventricular tachyarrhythmias. During this trial period, IV verapamil was given to 24 patients, 12 (50%) of which benefited from its use. IV verapam...
Gespeichert in:
Veröffentlicht in: | The American journal of emergency medicine 1987-05, Vol.5 (3), p.207-210 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 210 |
---|---|
container_issue | 3 |
container_start_page | 207 |
container_title | The American journal of emergency medicine |
container_volume | 5 |
creator | Shaw, Lewis C. Eitel, David R. Walton, Stacy L. Pollack, Marc |
description | Verapamil was introduced into a hospital-based urban/rural advanced life support (ALS) system for intravenous (IV) use in patients with symptomatic supraventricular tachyarrhythmias. During this trial period, IV verapamil was given to 24 patients, 12 (50%) of which benefited from its use. IV verapamil produced no harmful effects, and there was only one reported adverse effect (nausea) related to its administration. IV verapamil may be useful in the prehospital care of patients with symptomatic supraventricular tachyarrhythmias. |
doi_str_mv | 10.1016/0735-6757(87)90322-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77524777</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0735675787903226</els_id><sourcerecordid>77524777</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-a9792efeaa9a0967aa2a690623756f4c7fb63c89314caf8237ef85d4a60f5b8e3</originalsourceid><addsrcrecordid>eNp9kFtLAzEQhYMotVb_gUIfROrDarK57b4IUrxBQR_0OUyzE4zszWS34L93a5c-CgMDM98ZzhxCzhm9YZSpW6q5TJSWepHp65zyNE3UAZkyydMkY5odkukeOSYnMX5RypiQYkImXKRKKT4li7eAn01sfQflvI84b9zc112ADdZNH-cbDNBC5ctTcuSgjHg29hn5eHx4Xz4nq9enl-X9KrE8U10Cuc5TdAiQA82VBkhB5VSlXEvlhNVurbjNcs6EBZcNY3SZLAQo6uQ6Qz4jV7u7bWi-e4ydqXy0WJZQ42DIaC1TobUeQLEDbWhiDOhMG3wF4ccwarYBme33Zvu9ybT5C8ioQXYx3u_XFRZ70ZjIsL8c9xAtlC5AbX3cY1qKocSA3e0wHLLYeAwmWo-1xcIHtJ0pGv-_j1_m4oCi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77524777</pqid></control><display><type>article</type><title>Prehospital use of intravenous verapamil</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Shaw, Lewis C. ; Eitel, David R. ; Walton, Stacy L. ; Pollack, Marc</creator><creatorcontrib>Shaw, Lewis C. ; Eitel, David R. ; Walton, Stacy L. ; Pollack, Marc</creatorcontrib><description>Verapamil was introduced into a hospital-based urban/rural advanced life support (ALS) system for intravenous (IV) use in patients with symptomatic supraventricular tachyarrhythmias. During this trial period, IV verapamil was given to 24 patients, 12 (50%) of which benefited from its use. IV verapamil produced no harmful effects, and there was only one reported adverse effect (nausea) related to its administration. IV verapamil may be useful in the prehospital care of patients with symptomatic supraventricular tachyarrhythmias.</description><identifier>ISSN: 0735-6757</identifier><identifier>EISSN: 1532-8171</identifier><identifier>DOI: 10.1016/0735-6757(87)90322-6</identifier><identifier>PMID: 3426663</identifier><identifier>CODEN: AJEMEN</identifier><language>eng</language><publisher>Philadelphia, PA: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antiarythmic agents ; Biological and medical sciences ; Cardiovascular system ; Emergency Medical Services ; Female ; Humans ; Injections, Intravenous ; Male ; Medical sciences ; Middle Aged ; Monitoring, Physiologic ; Pharmacology. Drug treatments ; Prehospital treatment ; tachyarrhythmias ; tachycardia ; Tachycardia, Supraventricular - drug therapy ; Tachycardia, Supraventricular - physiopathology ; verapamil ; Verapamil - administration & dosage ; Verapamil - therapeutic use</subject><ispartof>The American journal of emergency medicine, 1987-05, Vol.5 (3), p.207-210</ispartof><rights>1987</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-a9792efeaa9a0967aa2a690623756f4c7fb63c89314caf8237ef85d4a60f5b8e3</citedby><cites>FETCH-LOGICAL-c386t-a9792efeaa9a0967aa2a690623756f4c7fb63c89314caf8237ef85d4a60f5b8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0735-6757(87)90322-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7547544$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3426663$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shaw, Lewis C.</creatorcontrib><creatorcontrib>Eitel, David R.</creatorcontrib><creatorcontrib>Walton, Stacy L.</creatorcontrib><creatorcontrib>Pollack, Marc</creatorcontrib><title>Prehospital use of intravenous verapamil</title><title>The American journal of emergency medicine</title><addtitle>Am J Emerg Med</addtitle><description>Verapamil was introduced into a hospital-based urban/rural advanced life support (ALS) system for intravenous (IV) use in patients with symptomatic supraventricular tachyarrhythmias. During this trial period, IV verapamil was given to 24 patients, 12 (50%) of which benefited from its use. IV verapamil produced no harmful effects, and there was only one reported adverse effect (nausea) related to its administration. IV verapamil may be useful in the prehospital care of patients with symptomatic supraventricular tachyarrhythmias.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antiarythmic agents</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Emergency Medical Services</subject><subject>Female</subject><subject>Humans</subject><subject>Injections, Intravenous</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Monitoring, Physiologic</subject><subject>Pharmacology. Drug treatments</subject><subject>Prehospital treatment</subject><subject>tachyarrhythmias</subject><subject>tachycardia</subject><subject>Tachycardia, Supraventricular - drug therapy</subject><subject>Tachycardia, Supraventricular - physiopathology</subject><subject>verapamil</subject><subject>Verapamil - administration & dosage</subject><subject>Verapamil - therapeutic use</subject><issn>0735-6757</issn><issn>1532-8171</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kFtLAzEQhYMotVb_gUIfROrDarK57b4IUrxBQR_0OUyzE4zszWS34L93a5c-CgMDM98ZzhxCzhm9YZSpW6q5TJSWepHp65zyNE3UAZkyydMkY5odkukeOSYnMX5RypiQYkImXKRKKT4li7eAn01sfQflvI84b9zc112ADdZNH-cbDNBC5ctTcuSgjHg29hn5eHx4Xz4nq9enl-X9KrE8U10Cuc5TdAiQA82VBkhB5VSlXEvlhNVurbjNcs6EBZcNY3SZLAQo6uQ6Qz4jV7u7bWi-e4ydqXy0WJZQ42DIaC1TobUeQLEDbWhiDOhMG3wF4ccwarYBme33Zvu9ybT5C8ioQXYx3u_XFRZ70ZjIsL8c9xAtlC5AbX3cY1qKocSA3e0wHLLYeAwmWo-1xcIHtJ0pGv-_j1_m4oCi</recordid><startdate>19870501</startdate><enddate>19870501</enddate><creator>Shaw, Lewis C.</creator><creator>Eitel, David R.</creator><creator>Walton, Stacy L.</creator><creator>Pollack, Marc</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19870501</creationdate><title>Prehospital use of intravenous verapamil</title><author>Shaw, Lewis C. ; Eitel, David R. ; Walton, Stacy L. ; Pollack, Marc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-a9792efeaa9a0967aa2a690623756f4c7fb63c89314caf8237ef85d4a60f5b8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antiarythmic agents</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Emergency Medical Services</topic><topic>Female</topic><topic>Humans</topic><topic>Injections, Intravenous</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Monitoring, Physiologic</topic><topic>Pharmacology. Drug treatments</topic><topic>Prehospital treatment</topic><topic>tachyarrhythmias</topic><topic>tachycardia</topic><topic>Tachycardia, Supraventricular - drug therapy</topic><topic>Tachycardia, Supraventricular - physiopathology</topic><topic>verapamil</topic><topic>Verapamil - administration & dosage</topic><topic>Verapamil - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shaw, Lewis C.</creatorcontrib><creatorcontrib>Eitel, David R.</creatorcontrib><creatorcontrib>Walton, Stacy L.</creatorcontrib><creatorcontrib>Pollack, Marc</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shaw, Lewis C.</au><au>Eitel, David R.</au><au>Walton, Stacy L.</au><au>Pollack, Marc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prehospital use of intravenous verapamil</atitle><jtitle>The American journal of emergency medicine</jtitle><addtitle>Am J Emerg Med</addtitle><date>1987-05-01</date><risdate>1987</risdate><volume>5</volume><issue>3</issue><spage>207</spage><epage>210</epage><pages>207-210</pages><issn>0735-6757</issn><eissn>1532-8171</eissn><coden>AJEMEN</coden><abstract>Verapamil was introduced into a hospital-based urban/rural advanced life support (ALS) system for intravenous (IV) use in patients with symptomatic supraventricular tachyarrhythmias. During this trial period, IV verapamil was given to 24 patients, 12 (50%) of which benefited from its use. IV verapamil produced no harmful effects, and there was only one reported adverse effect (nausea) related to its administration. IV verapamil may be useful in the prehospital care of patients with symptomatic supraventricular tachyarrhythmias.</abstract><cop>Philadelphia, PA</cop><pub>Elsevier Inc</pub><pmid>3426663</pmid><doi>10.1016/0735-6757(87)90322-6</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0735-6757 |
ispartof | The American journal of emergency medicine, 1987-05, Vol.5 (3), p.207-210 |
issn | 0735-6757 1532-8171 |
language | eng |
recordid | cdi_proquest_miscellaneous_77524777 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adult Aged Aged, 80 and over Antiarythmic agents Biological and medical sciences Cardiovascular system Emergency Medical Services Female Humans Injections, Intravenous Male Medical sciences Middle Aged Monitoring, Physiologic Pharmacology. Drug treatments Prehospital treatment tachyarrhythmias tachycardia Tachycardia, Supraventricular - drug therapy Tachycardia, Supraventricular - physiopathology verapamil Verapamil - administration & dosage Verapamil - therapeutic use |
title | Prehospital use of intravenous verapamil |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A01%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prehospital%20use%20of%20intravenous%20verapamil&rft.jtitle=The%20American%20journal%20of%20emergency%20medicine&rft.au=Shaw,%20Lewis%20C.&rft.date=1987-05-01&rft.volume=5&rft.issue=3&rft.spage=207&rft.epage=210&rft.pages=207-210&rft.issn=0735-6757&rft.eissn=1532-8171&rft.coden=AJEMEN&rft_id=info:doi/10.1016/0735-6757(87)90322-6&rft_dat=%3Cproquest_cross%3E77524777%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77524777&rft_id=info:pmid/3426663&rft_els_id=0735675787903226&rfr_iscdi=true |